Listing 1 - 8 of 8 |
Sort by
|
Choose an application
Is it sensible to screen for breast or prostate cancer? Should the locations of cancer clusters be made available to the general public? When a doctor wants to perform major surgery and there's no chance for a second opinion, do you agree?The answers to these questions are not as black and white as they may first appear. Medical Illuminations presents thirteen contemporary medical topics, from the diminishing value of mammograms to how to decide if a hip needs to be replaced, to understanding cancer maps. In each case it illustrates how modern tools of statistical thinking and statistical grap
Medical innovations. --- Innovations, Medical --- Medicine --- Medical technology --- Technological innovations --- Innovations
Choose an application
The recent emphasis in biomedical research on translational biology and personalized medicine is revolutionizing conceptual and experimental approaches to understanding and improving human health. Translational Biology in Medicine begins with an introduction to experimental model systems for disease, such as cell lines, primary cells, stem cells and animal models for disease, followed by a systematic description of genetic and genomic profiling and biomarker validation currently used in biomedical research. Examples of translation studies that have used these models and methods are presented,
Medicine, Experimental. --- Medical innovations. --- Innovations, Medical --- Medicine --- Medical technology --- Technological innovations --- Experimental medicine --- Innovations --- Research
Choose an application
Frontiers in Clinical Drug Research - Anti infectives is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antif
Anti-infective agents. --- Clinical medicine. --- Medical innovations. --- Innovations, Medical --- Medicine --- Medical technology --- Technological innovations --- Medicine, Clinical --- Antiinfective agents --- Antimicrobial agents --- Antimicrobial drugs --- Antimicrobials --- Drugs --- Innovations
Choose an application
"Scholars and policymakers alike agree that innovation in the biosciences is key to future growth. The field continues to shift and expand, and it is certainly changing the way people live their lives in a variety of ways. But despite the lion's share of federal research dollars being devoted to innovation in the biosciences, the field has yet to live up to its billing as a source of economic productivity and growth. With vast untapped potential to imagine and innovate in the biosciences, adaptation of the innovative model is needed. In The Biologist's Imagination, William Hoffman and Leo Furcht examine the history of innovation in the biosciences, tracing technological innovation from the late eighteenth century to the present and placing special emphasis on how and where technology evolves. Place is key to innovation, from the early industrial age to the rise of the biotechnology industry in the second half of the twentieth century. The book uses the distinct history of bioscientific innovation to discuss current trends as they relate to medicine, agriculture, biofuels, stem-cell research, neuroscience, and more. Ultimately, Hoffman and Furcht argue that, as things currently stand, we fall short in our efforts to innovate in the biosciences; our system of innovation is itself in need of innovation. It needs to adapt to the massive changes brought about by converging technologies, globalization in higher education as well as in finance, and increases in entrepreneurship. The Biologist's Imagination is both an analysis of past models for bioscience innovation and a forward-looking, original argument for how future models should be developed"-- Provided by publisher "Discusses the history of technological innovation in the biosciences"-- Provided by publisher
Medical innovations. --- Biology --- Life sciences --- Biosciences --- Sciences, Life --- Science --- Biomass --- Life (Biology) --- Natural history --- Innovations, Medical --- Medicine --- Medical technology --- Technological innovations --- Technological innovations. --- Innovations
Choose an application
The origin of modern science is often located in Europe and the West. This Euro/West-centrism relegates emergent practices elsewhere to the periphery, undergirding analyses of contemporary transnational science and technology with traditional but now untenable hierarchical categories. In this book, Amit Prasad examines features of transnationality in science and technology through a study of magnetic resonance imaging research and development in the United States, Britain, and India.
Magnetic resonance imaging --- Medical innovations. --- History. --- Clinical magnetic resonance imaging --- Diagnostic magnetic resonance imaging --- Functional magnetic resonance imaging --- Imaging, Magnetic resonance --- Medical magnetic resonance imaging --- MR imaging --- MRI (Magnetic resonance imaging) --- NMR imaging --- Nuclear magnetic resonance --- Nuclear magnetic resonance imaging --- Innovations, Medical --- Medicine --- Diagnostic use --- Innovations --- Technological innovations --- Cross-sectional imaging --- Diagnostic imaging --- Medical technology
Choose an application
This book outlines risk assessments for 28 diseases and medical conditions including the following aspects: genetics, biochemistry, serology, past medical history, family history, co-morbidities, age, gender, ethnicity, nutrition and lifestyle. Recommendations are made for how to avoid, eliminate or mitigate risks. Preventing measures concerning chemical compound intake, lifestyle and nutrition are proposed. The unique content and approach of the book to chronic disease management make it a state-of-the-art reference work, addressing a missing component of medical care and reflecting the cutting edge of preventive medicine.
Medical innovations. --- Innovations, Medical --- Medicine --- Medical technology --- Technological innovations --- Innovations --- Medicine. --- Oncology . --- Diabetes. --- Public Health. --- Health Promotion and Disease Prevention. --- Oncology. --- Brittle diabetes --- Diabetes mellitus --- IDDM (Disease) --- Insulin-dependent diabetes --- Ketosis prone diabetes --- Type 1 diabetes --- Carbohydrate intolerance --- Endocrine glands --- Diabetic acidosis --- Glycosylated hemoglobin --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Tumors --- Diseases --- Health Workforce --- Public health. --- Health promotion. --- Health promotion programs --- Health promotion services --- Promotion of health --- Wellness programs --- Preventive health services --- Health education --- Community health --- Health services --- Hygiene, Public --- Hygiene, Social --- Public health services --- Public hygiene --- Social hygiene --- Health --- Human services --- Biosecurity --- Health literacy --- Medicine, Preventive --- National health services --- Sanitation
Choose an application
New medical technologies are a leading driver of U.S. health care spending. This report identifies promising policy options to change which medical technologies are created, with two related policy goals: (1) Reduce total health care spending with the smallest possible loss of health benefits, and (2) ensure that new medical products that increase spending are accompanied by health benefits that are worth the spending increases.
Medical care, Cost of --- Medical care --- Medical technology --- Drug approval --- Medicare --- Public Policy --- Economics --- Technology --- Evaluation Studies as Topic --- Consumer Product Safety --- Social Control Policies --- Health Care Economics and Organizations --- Public Health --- Investigative Techniques --- Technology, Industry, and Agriculture --- Environment and Public Health --- Health Care --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Social Control, Formal --- Policy --- Technology, Industry, Agriculture --- Sociology --- Social Sciences --- Anthropology, Education, Sociology and Social Phenomena --- Health Policy --- Economics, Medical --- Device Approval --- Biomedical Technology --- Costs and Cost Analysis --- Health & Biological Sciences --- Medical Economics --- Technological innovations --- Cost effectiveness --- Medical innovations. --- Innovations, Medical --- Medicine --- Innovations
Choose an application
The transformative potential of genetic and cybernetic technologies to enhance human capabilities is most often either rejected on moral and prudential grounds or hailed as the future salvation of humanity. In this book, Nicholas Agar offers a more nuanced view, making a case for moderate human enhancement -- improvements to attributes and abilities that do not significantly exceed what is currently possible for human beings. He argues against radical human enhancement, or improvements that greatly exceed current human capabilities. Agar explores notions of transformative change and motives for human enhancement; distinguishes between the instrumental and intrinsic value of enhancements; argues that too much enhancement undermines human identity; considers the possibility of cognitively enhanced scientists; and argues against radical life extension. Making the case for moderate enhancement, Agar argues that many objections to enhancement are better understood as directed at the degree of enhancement rather than enhancement itself. Moderate human enhancement meets the requirement of truly human enhancement. By radically enhancing human cognitive capabilities, by contrast, we may inadvertently create beings ("post-persons") with moral status higher than that of persons. If we create beings more entitled to benefits and protections against harms than persons, Agar writes, this will be bad news for the unenhanced. Moderate human enhancement offers a more appealing vision of the future and of our relationship to technology.
Bioethik. --- Biomedical Technology --- Biotechnologie. --- Biotechnology --- Diffusion of Innovation. --- Enhancement. --- Ethics, Medical. --- Genetic Enhancement --- Genetic engineering --- Medical ethics. --- Medical innovations --- Technology Assessment, Biomedical --- ethics. --- Moral and ethical aspects. --- Philosophy. --- Biomedical ethics --- Clinical ethics --- Ethics, Medical --- Health care ethics --- Medical care --- Medicine --- Bioethics --- Professional ethics --- Nursing ethics --- Social medicine --- Designed genetic change --- Engineering, Genetic --- Gene splicing --- Genetic intervention --- Genetic surgery --- Genetic recombination --- Transgenic organisms --- Innovations, Medical --- Medical technology --- Technological innovations --- Moral and ethical aspects --- Innovations --- PHILOSOPHY/Ethics & Bioethics --- PHILOSOPHY/General --- SCIENCE, TECHNOLOGY & SOCIETY/General --- Philosophy of science --- Professional ethics. Deontology --- Human medicine --- Medical ethics --- Philosophy --- Ethics.
Listing 1 - 8 of 8 |
Sort by
|